Disclosures for "Drug Eruption After Subcutaneous Ofatumumab Exposure in Two Patients with Relapsing Multiple Sclerosis "
Dr. Bou Reslan has nothing to disclose.
Dr. Aoun has nothing to disclose.
Dr. Abou Fayssal has nothing to disclose.